Ali Naushad, Tardif Keith D, Siddiqui Aleem
Department of Microbiology and Program in Molecular Biology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
J Virol. 2002 Dec;76(23):12001-7. doi: 10.1128/jvi.76.23.12001-12007.2002.
The hepatitis C virus (HCV) contains a plus-strand RNA genome. The 5' noncoding region (NCR) of the viral genome functions as an internal ribosome entry site, and its unique 3' NCR is required for the assembly of the replication complex during initiation of HCV RNA replication. Lohmann et al. (V. Lohmann, F. Korner, J.-O. Koch, U. Herian, L. Theilman, and R. Batenschlager, Science 285:110-113, 1999) developed a subgenomic HCV replicon system, which represents an important tool in studying HCV replication in cultured cells. In this study, we describe a cell-free replication system that utilizes cytoplasmic lysates prepared from Huh-7 cells harboring the HCV subgenomic replicons. These lysates, which contain ribonucleoprotein complexes associated with cellular membranes, were capable of incorporating [alpha(32)P]CTP into newly synthesized RNA from subgenomic replicons in vitro. Replicative forms (RFs) and replicative intermediates (RIs) were synthesized from the endogenous HCV RNA templates. Consistent with previous observations, RFs were found to be resistant to RNase A digestion, whereas RIs were sensitive to RNase treatment. The radiolabeled HCV RF-RI complexes contained both minus and plus strands and were specific to the lysates derived from replicon-expressing cells. The availability of a cell-free replication system offers opportunities to probe the mechanism(s) of HCV replication. It also provides a novel assay for potential therapeutic agents.
丙型肝炎病毒(HCV)含有一条正链RNA基因组。病毒基因组的5'非编码区(NCR)作为内部核糖体进入位点发挥作用,其独特的3'NCR是HCV RNA复制起始时复制复合体组装所必需的。Lohmann等人(V. Lohmann、F. Korner、J.-O. Koch、U. Herian、L. Theilman和R. Batenschlager,《科学》285:110 - 113,1999年)开发了一种亚基因组HCV复制子系统,这是研究HCV在培养细胞中复制的重要工具。在本研究中,我们描述了一种无细胞复制系统,该系统利用从携带HCV亚基因组复制子的Huh - 7细胞制备的细胞质裂解物。这些裂解物含有与细胞膜相关的核糖核蛋白复合体,能够在体外将[α(32)P]CTP掺入来自亚基因组复制子的新合成RNA中。复制形式(RFs)和复制中间体(RIs)是从内源性HCV RNA模板合成的。与先前的观察结果一致,发现RFs对RNase A消化具有抗性,而RIs对RNase处理敏感。放射性标记的HCV RF - RI复合体同时含有负链和正链,并且对来自表达复制子的细胞的裂解物具有特异性。无细胞复制系统的可用性为探究HCV复制机制提供了机会。它还为潜在治疗药物提供了一种新的检测方法。